...
首页> 外文期刊>International Journal of Pharmaceutics >Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact on in vitro dissolution behavior
【24h】

Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact on in vitro dissolution behavior

机译:溶解介质中溶于阳离子药物和十二烷基硫酸钠之间的相互作用及其对体外溶解行为的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Abstract In the pharmaceutical industry, in vitro dissolution testing ofsolid oral dosage forms is a very important tool for drug development and quality control. However, ion-pairing interaction between the ionic drugand surfactants in dissolution medium often occurs, resulting in inconsistent and incomplete drug release. The aim of this study is toevaluate the effects ofsodium dodecyl sulfate (SDS) mediated medium onthe dissolution behaviors of a poorly soluble cationic drug (Drug B). The study was carried out by measuring solubility of Drug B substance and dissolution rate of Drug B product in media containing SDS.Desolubilization of Drug B substance was observed at pH 4.5 in the presence of SDS at concentrations below critical micelle concentration (CMC) which is attributed to the formation of an insoluble di-dodecyl sulfate salt between SDS and Drug B. This ion-pairing effect is less significant with increasing medium pH where Drug B is less ionized and CMC of SDS is lower. In medium at pH 4.5, dissolution of Drug B product was found incomplete with SDS concentration below CMC due to the desolubilization of Drug B substance. In media with SDS level above CMC, the dissolution rate is rather slower with higher inter-vessel variations compared to that obtained in pH 4.5 medium without SDS. The dissolution results demonstrate that the presence of SDS in medium generates unexpected irregular dissolution profiles for Drug B which are attributed to incompatible dissolution medium for this particular drug. Therefore, non-ionic surfactant was selected for Drug B product dissolution method and ion-pairing effect in SDS mediated medium should be evaluated when developing a dissolution method for any poorly soluble cationic drugs.
机译:图解摘要显示摘要在制药工业中,体外溶出试验对血岭口服剂型是药物开发和质量控制的一个非常重要的工具。然而,在溶解介质中的离子药物和表面活性剂之间的离子配对相互作用经常发生,导致药物释放不一致和不完全。本研究的目的是对硫酸钠(SDS)介导的培养基对溶于可溶性阳离子药物(药物B)的溶解行为的影响。该研究通过测量药物B物质的溶解性和药物B产品的溶解速率含有SDS的培养基中的产物。在pH 4.5的浓度低于临界胶束浓度(CMC)的浓度下,在pH 4.5下观察到药物B物质的溶解物。归因于在SDS和药物B之间形成不溶性二甲基硫酸盐盐。该离子配对效应与增加的培养基pH值不太显着,其中药物B不太电离,SDS的CMC较低。在pH 4.5的培养基中,由于药物B物质的脱溶解,发现药物B产品的溶解不完全在CMC以下。在CMC高于CMC的培养基中,与在没有SDS的pH 4.5培养基中获得的相比,溶出速率相当较慢,较高的血管内变化。溶解结果表明,培养基中的SDS存在产生意外的不相同溶解曲线,其归因于该特定药物的不相容溶解介质。因此,选择非离子表面活性剂用于药物B产物溶解方法,并且在为任何可溶于阳离子药物的溶解方法开发溶解方法时,应评估SDS介导的介质中的离子配对效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号